|
KMID : 1141720220100010025
|
|
폐쇄성폐질환
2022 Volume.10 No. 1 p.25 ~ p.32
|
|
|
ICS for Non-asthmatic Chronic Cough (Con)
|
|
Kim Sung-Kyoung
|
|
|
Abstract
|
|
|
|
There are no standard guidelines for the management of non-asthmatic chronic cough (NACC), and in particular, the use of inhaled corticosteroid (ICS) for cough control in NACC has some controversies so far. Although several clinical studies have reported that the use of ICS in NACC is effective to cough control, a closer look at those studies shows that a number of patients with factors that can respond well to ICS are included in the treatment group. It is considered that recommending the use of ICS for cough control in NACC based solely on the results of these studies might be unreasonable. However, it is thought that there is a group in which ICS can be effective for cough control in patients with NACC. It is important to identify the characteristics of the patient group in which ICS can be effective for cough control in NACC through appropriate clinical studies in the future.
|
|
|
KEYWORD
|
|
|
Non-asthmatic chronic cough, Treatment, Inhaled corticosteroid
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|